Explore

Rapid Read Rapid Read
ASTAR Genome Institute Develops sm-PORE-cupine Technique for RNA Structural Analysis

ASTAR Genome Institute Develops sm-PORE-cupine Technique for RNA Structural Analysis

Researchers at the ASTAR Genome Institute of Singapore have introduced a new technique called sm-PORE-cupine, which allows for the detailed examination of individual RNA molecules. This method reveals the complex folding patterns and structures of RNA, which are crucial for understanding gene regulation and disease mechanisms. The technique integrates site-specific chemical labeling with nanopore-based direct RNA sequencing, enabling the detection of structural features in real-time. This advancement provides unprecedented resolution in RNA structural profiling, capturing diverse conformations within cell samples.
Trendline Trendline
New RNA-seq Technology CIPHER-seq Enhances Cancer Research by Simultaneously Quantifying RNA and Proteins

New RNA-seq Technology CIPHER-seq Enhances Cancer Research by Simultaneously Quantifying RNA and Proteins

New RNA-seq Technology CIPHER-seq Enhances Cancer Research by Simultaneously Quantifying RNA and Proteins
Trendline Trendline
New RNA-seq Technology CIPHER-seq Enhances Cancer Research by Simultaneously Quantifying Proteins and Transcriptomes

New RNA-seq Technology CIPHER-seq Enhances Cancer Research by Simultaneously Quantifying Proteins and Transcriptomes

New RNA-seq Technology CIPHER-seq Enhances Cancer Research by Simultaneously Quantifying Proteins and Transcriptomes
Trendline Trendline
ApexGO: AI-Driven Method Revolutionizes Antibiotic Discovery

ApexGO: AI-Driven Method Revolutionizes Antibiotic Discovery

ApexGO: AI-Driven Method Revolutionizes Antibiotic Discovery
Trendline Trendline
University of Pennsylvania Develops ApexGO for Faster Antibiotic Discovery

University of Pennsylvania Develops ApexGO for Faster Antibiotic Discovery

University of Pennsylvania Develops ApexGO for Faster Antibiotic Discovery
Trendline Trendline
Functional Peptide Screening Emerges as Key Differentiator in GPCR and Radiopharma Research

Functional Peptide Screening Emerges as Key Differentiator in GPCR and Radiopharma Research

Functional Peptide Screening Emerges as Key Differentiator in GPCR and Radiopharma Research
Rapid Read Rapid Read
UMBC Researchers Identify Key Mechanism in Enterovirus Replication, Paving Way for New Antiviral Drugs

UMBC Researchers Identify Key Mechanism in Enterovirus Replication, Paving Way for New Antiviral Drugs

Researchers at the University of Maryland, Baltimore County (UMBC) have made a significant discovery regarding how enteroviruses, which include pathogens responsible for polio and the common cold, replicate within human cells. The study, published in Nature Communications, was led by Deepak Koirala and Naba Krishna Das. It reveals that these viruses use a specific RNA structure to recruit proteins necessary for replication. The research highlights the role of a fusion protein, 3CD, which is crucial for the virus to multiply. The 3C portion of this protein cuts amino acid chains into necessary proteins, while the 3D portion acts as an RNA polymerase, copying the viral RNA. This discovery could lead to the development of broad-spectrum antiviral drugs targeting multiple enteroviruses.
Rapid Read Rapid Read
Innovative Monovalent Degraders Enhance SMARCA 2/4 Degradation in Cancer Cells

Innovative Monovalent Degraders Enhance SMARCA 2/4 Degradation in Cancer Cells

A recent study published in Nature explores the use of monovalent degraders to recruit dual E3 ligases, enhancing the degradation of SMARCA 2/4 proteins in cancer cells. The research highlights the development of a novel strategy that utilizes monovalent and compact degrader designs to overcome resistance mechanisms typically associated with E3 ligase mutations or downregulation. The study involved generating SMARCA4-HiBit HEK293T single-KO cell lines and employing CRISPR/Cas9 technology to confirm the successful knockout of target genes. The findings suggest that these degraders can chemically toggle between distinct E3 ligases, potentially improving therapeutic efficacy and addressing resistance in cancer treatment.
Trendline Trendline
GenScript Unveils TurboCHO Protein Expression Kit for Faster Antibody Development

GenScript Unveils TurboCHO Protein Expression Kit for Faster Antibody Development

GenScript Unveils TurboCHO Protein Expression Kit for Faster Antibody Development
Trendline Trendline
Silence Therapeutics to Present at H.C. Wainwright BioConnect Investor Conference Highlighting siRNA Therapies

Silence Therapeutics to Present at H.C. Wainwright BioConnect Investor Conference Highlighting siRNA Therapies

Silence Therapeutics to Present at H.C. Wainwright BioConnect Investor Conference Highlighting siRNA Therapies
Rapid Read Rapid Read
Stowers Institute Develops AI Model to Predict Cell Fate and Address Cancer

Stowers Institute Develops AI Model to Predict Cell Fate and Address Cancer

Researchers at the Stowers Institute of Medical Research have developed an AI model named RegVelo, which integrates gene-regulatory networks with single-cell biology to predict how cells change over time. This model, detailed in a study published in Cell, aims to bridge the gap between understanding cell state transitions and the gene regulatory networks that control these changes. The research highlights the model's application in zebrafish neural crest development, identifying key regulators of pigment cell formation. The model's predictions were validated using CRISPR/Cas9-mediated knockout and single-cell Perturb-seq, demonstrating its potential to generate biologically meaningful hypotheses. The study suggests that RegVelo's applications extend beyond neural crest cells, potentially impacting developmental biology and cancer treatment modeling.
Rapid Read Rapid Read
UBC Okanagan Researchers Decode Cancer-Fighting Plant Compound, Paving Way for Sustainable Production

UBC Okanagan Researchers Decode Cancer-Fighting Plant Compound, Paving Way for Sustainable Production

Researchers at UBC Okanagan have made a significant breakthrough in understanding how plants produce mitraphylline, a rare compound with potential cancer-fighting properties. Mitraphylline is part of a unique class of plant chemicals known as spirooxindole alkaloids, which are noted for their complex structures and biological effects, including anti-inflammatory and anti-tumor activities. The research team, led by Dr. Thu-Thuy Dang, identified two critical enzymes that are essential in the production of mitraphylline. This discovery answers longstanding questions about the molecular processes plants use to create these compounds and opens new avenues for replicating them in laboratories. The research was a collaborative effort with the University of Florida and received funding from several Canadian and U.S. institutions.